Stock 600161 BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Beijing Tiantan Biological Products Co., Ltd.

Equities

600161

CNE000000WF9

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
28.55 CNY -0.80% Intraday chart for Beijing Tiantan Biological Products Co., Ltd. -0.49% -7.72%
12/04 Tiantan Biological Products' Q1 Profit Jumps 21%; Shares Rise 7% MT
11/04 Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The Company mainly distributes its products within domestic markets and to Hong Kong markets.

Number of employees: 4,858

Sales per Business

CNY in Million2022Weight2023Weight Delta
Blood Products
99.6 %
4,244 99.6 % 5,162 99.6 % +21.62%
Others
0.4 %
17 0.4 % 18 0.4 % +9.03%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
4,131 97.3 % 5,163 100.0 % +25.00%
Foreign
0.0 %
114 2.7 % 2 0.0 % -98.15%

Managers

Managers TitleAgeSince
Dao Xing Fu CEO
 Chief Executive Officer 60 25/17/25
Hui Chuan Yang CHM
 Chairman 57 01/11/01
Bo Tian IRC
 Investor Relations Contact - 01/06/01
Xiang Ci SEC
 Corporate Secretary 45 01/03/01
Yi Zhang PRN
 Corporate Officer/Principal 54 01/00/01

Members of the board

Members of the board TitleAgeSince
Yan Fang BRD
 Director/Board Member 56 23/20/23
Hui Chuan Yang CHM
 Chairman 57 01/11/01
Fen Ling Gu BRD
 Director/Board Member 61 23/20/23
Li Gang Hu BRD
 Director/Board Member 50 25/17/25
Jing Jin Zhu CHM
 Chairman 62 01/16/01
Dao Xing Fu CEO
 Chief Executive Officer 60 25/17/25
Xiang Rong Li BRD
 Director/Board Member 54 23/20/23
Hong Guang Wang BRD
 Director/Board Member 62 -
Jian Ming Wang BRD
 Director/Board Member 53 23/20/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,647,809,538 749,886,224 ( 45.51 %) 0 45.51 %

Shareholders

NameEquities%Valuation
China State-Owned Assets Supervision & Admn Commission
50.12 %
825,933,574 50.12 % 3 089 M ¥
Wen Shi
2.654 %
43,738,338 2.654 % 164 M ¥
Xiao Hui Qiao
1.959 %
32,276,467 1.959 % 121 M ¥
Zhong Ou Asset Management Co., Ltd
1.930 %
31,810,803 1.930 % 119 M ¥
China International Capital Corp. Ltd. (Invt Management)
1.766 %
29,107,326 1.766 % 109 M ¥
Aegon-Industrial Fund Management Co., Ltd.
1.182 %
19,483,152 1.182 % 73 M ¥
China Merchants Fund Management Co., Ltd.
1.079 %
17,778,007 1.079 % 66 M ¥
Li Guo Zhang
0.7777 %
12,814,540 0.7777 % 48 M ¥
Citic Securities Co., Ltd. (Invt Port)
0.7243 %
11,935,409 0.7243 % 45 M ¥
Bosera Asset Management Co., Ltd.
0.6842 %
11,273,584 0.6842 % 42 M ¥

Company contact information

Beijing Tiantan Biological Products Corp. Ltd.

1/F, Block A 2 Courtyard, Shuangqiao Road

100024, Beijing

+

http://www.tiantanbio.com
address Beijing Tiantan Biological Products Co., Ltd.(600161)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Beijing Tiantan Biological Products Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
28.55 CNY
Average target price
31.86 CNY
Spread / Average Target
+11.58%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD. Stock Beijing Tiantan Biological Products Co., Ltd.
-7.72% 6.49B
CSL LIMITED Stock CSL Limited
-4.66% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.09% 15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 600161 Stock
  4. Company Beijing Tiantan Biological Products Co., Ltd.